Surmodics, Inc. (SRDX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 33.33 |
| Open | 34.36 |
| Bid | 34.28 x 100 |
| Ask | 34.59 x 100 |
| Day's Range | 33.25 - 35.45 |
| 52 Week Range | 16.79 - 39.41 |
| Volume | |
| Avg. Volume | 67,124 |
| Market Cap | 491.854M |
| Beta (5Y Monthly) | 1.02 |
| PE Ratio (TTM) | 88.59 |
| EPS (TTM) | 0.39 |
| Earnings Date | Jul 31, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 58.00 |
- GuruFocus.com
Surmodics Inc (SRDX) Q2 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and ...
Surmodics Inc reports significant gains in medical device sales and operational achievements, despite challenges in the IVD segment.
ZacksSurModics (SRDX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for SurModics (SRDX) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
ZacksSurModics (SRDX) Q2 Earnings and Revenues Top Estimates
SurModics (SRDX) delivered earnings and revenue surprises of 119.44% and 11.02%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.